Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 2—February 2002


Traditional and Molecular Techniques for the Study of Emerging Bacterial Diseases: One Laboratory’s Perspective

Pierre Houpikian and Didier RaoultComments to Author 
Author affiliations: Unité des Rickettsies, Faculté de Médecine de Marseille, Marseille, France

Main Article

Table 2

Key issues for isolating main emerging bacteria

Conditions for incubation
Group Axenic specific medium Living system (embryonated egg,
cell line) Low temperature
(<37°C) O2 and CO2 conditions Extended incubation
Alpha1 Proteo-
bacteriae Ehrlichia sp.
Rickettsia sp.
Chlamydia sp. ELB agent
(“Rickettsia felis”) (28°C) Ehrlichia sp.
Rickettsia sp.
Alpha2 Proteo-
bacteriae Afipia sp. Afipia sp.
Bartonella sp. Bartonella bacilliformis (28°C) Bartonella sp.
Spirochetae Borrelia sp. Treponema pallidum
Delta-Xi Proteo-
bacteriae Campylobacter sp. (microaerophilic)
Helicobacter sp. (microaerophilic) Helicobacter pylori
Gamma Proteo-
bacteriae Legionella sp. Legionella sp. Yersinia pestis
Mycobacteria Mycobacterium sp. Mycobacterium leprae Mycobacterium malmoense (microaerophilic) Mycobacterium sp.
Mycoplasmas Mycoplasma sp. Mycoplasma fermentans
Gram-positive bacteria Tropheryma whipplei Clostridium difficile
(anaerobic) Tropheryma whipplei

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO